Managing complexity across biopharma modalities
SK pharmteco CEO Joerg Ahlgrimm discusses complexity, global pressure and drug development speed.
SK pharmteco CEO Joerg Ahlgrimm discusses complexity, global pressure and drug development speed.
SK pharmteco CEO Joerg Ahlgrimm discusses complexity, global pressure and drug development speed.
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.